Raysa Morales‐Demori

Attenuation of the side effect profile of regadenoson: A randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. “The ASSUAGE trial”

Rami Doukky, Raysa Morales‐Demori, Sidharth Jain et al. · Journal of Nuclear Cardiology · 2012 · 58 citations

Side Effect Profile, Cardiovascular Disease, Myocardial Perfusion Imaging +9

Epidemiology of Pediatric Heart Failure in the USA–a 15-Year Multi-Institutional Study

Raysa Morales‐Demori, Elena Montañés, Gwen Erkonen et al. · Pediatric Cardiology · 2021 · 17 citations

Heart Failure, Cardiovascular Epidemiology, Health Policy +11

The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: A substudy of the ASSUAGE trial

Wassim Ballany, Khaled Mansour, Raysa Morales‐Demori et al. · Journal of Nuclear Cardiology · 2014 · 14 citations

Heart Failure, Radiology, Assuage Trial +9

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials

Maria Octavia Rangel, Raysa Morales‐Demori, Sarah T. Voll et al. · Journal of Nuclear Cardiology · 2014 · 13 citations

Assuage-ckd Trials, Heart Failure, Renal Function +7

Age and Gender as Predictors of Benefit From Aminophylline Administration in Patients Undergoing Regadenoson Stress Myocardial Perfusion Imaging

Maria Octavia Rangel, Raysa Morales‐Demori, Rami Doukky · American Journal of Therapeutics · 2013 · 10 citations

Heart Failure, Aminophylline Administration, Cardiovascular Pharmacology +16